dCE-2
Ref. TM-T200309
10mg | To inquire | ||
50mg | To inquire |
Product Information
dCE-2, a PROTAC compound, specifically targets CBP/EP300. It comprises several key components: the E3 ubiquitin ligase ligand Thalidomide-4-OH, the PROTAC linker tert-Butyl 11-aminoundecanoate, and the PROTAC target protein ligand EP300/CBP ligand 2. The activity of the target protein ligand is regulated by EP300/CBP ligand 1. Additionally, the conjugate of the E3 ubiquitin ligase ligand and linker is denoted as Thalidomide-NH-C10-Boc.
Chemical properties
Technical inquiry about: TM-T200309 dCE-2
If you want to request a quotation or place an order, please instead add the desired products to your cart and then request a quotation or order from the cart. It is faster, cheaper, and you will be able to benefit from the available discounts and other advantages.